# EDGAR Filing Document

**Accession Number:** 0000928054
**File Stem:** 0000928054-25-000092
**Filing Date:** 2025-11
**Character Count:** 63374
**Document Hash:** f072d819ecfc6dac0a9ec31fec06b799
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000928054-25-000092.hdr.sgml**: 20251104

**ACCESSION NUMBER**: 0000928054-25-000092

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 47

**CONFORMED PERIOD OF REPORT**: 20251104

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251104

**DATE AS OF CHANGE**: 20251104

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** FLOTEK INDUSTRIES INC/CN/
- **CENTRAL INDEX KEY:** 0000928054
- **STANDARD INDUSTRIAL CLASSIFICATION:** MISCELLANEOUS CHEMICAL PRODUCTS [2890]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 900023731
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-13270
- **FILM NUMBER:** 251449076

**BUSINESS ADDRESS:**
- **STREET 1:** 5775 N. SAM HOUSTON PARKWAY W.
- **STREET 2:** SUITE 400
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77086
- **BUSINESS PHONE:** 7138499911

**MAIL ADDRESS:**
- **STREET 1:** 5775 N. SAM HOUSTON PARKWAY W.
- **STREET 2:** SUITE 400
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77086

?xml version='1.0' encoding='ASCII'? ftk-20251104

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**November 4, 2025**

Date of Report (Date of earliest event reported)

**Flotek Industries, Inc.**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-13270** | **90-0023731** |
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |

---

**5775 N. Sam Houston Parkway W., Suite 400 Houston, TX, 77086**

(Address of principal executive office and zip code)

**(713) 849-9911** 

(Registrant's telephone number, including area code)

**(Not applicable)**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐&nbsp;&nbsp;&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐&nbsp;&nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **<u>Title of each class</u>** | **<u>Trading Symbol(s)</u>** | **<u>Name of Exchange on which registered</u>** |
| Common Stock, $0.0001 par value | FTK | NYSE |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **Item 2.02** | **Results of Operations and Financial Condition** |

---

On November 4, 2025, Flotek Industries, Inc. (the "Company") issued a press release providing its financial results for the quarter ended September 30, 2025 and announcing that it will hold a conference call to discuss its financial and operating results. The press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information furnished pursuant to Item 2.02 of this Current Report on Form 8-K and in Exhibit 99.1 shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is not subject to the liabilities of that section and is not deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as otherwise expressly stated in such filing.

---

| | |
|:---|:---|
| **Item 7.01** | **Regulation FD Disclosure** |

---

On November 4, 2025, the Company provided on its website a presentation containing information relating to its current operations and financial results. A copy of the presentation is attached hereto as Exhibit 99.2 and is incorporated herein by reference.

The information furnished pursuant to Item 7.01 of this Current Report on 8-K and in Exhibit 99.2 shall not be deemed to be "filed" for the purposes of the Exchange Act, is not subject to the liabilities of that section and is not deemed incorporated by reference into any filing of the Company under the Securities Act or the Exchange Act, except as otherwise expressly stated in such filing.

---

| | |
|:---|:---|
| **Item 9.01** | **Financial Statements and Exhibits.** |

---

**d) Exhibits.** 

---

| | |
|:---|:---|
| **Exhibit Number** | **Description** |
| 99.1 | <u>[Press Release dated](ex991-q32025.htm)[November 4](ex991-q32025.htm)[, 2025](ex991-q32025.htm)</u> |
| 99.2 | <u>[Presentation of Flotek Industries, Inc.](flotek3q2025earningspres.htm)</u> |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | **FLOTEK INDUSTRIES, INC.** | **FLOTEK INDUSTRIES, INC.** |
| Date: November 4, 2025 | /s/ Bond Clement | /s/ Bond Clement |
| | Name: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bond Clement |
| | Title: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chief Financial Officer |

---

## Exhibit 99.1

![blueflotekheader.jpg](blueflotekheader.jpg)

**Exhibit 99.1**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**Flotek Reports 95% Gross Profit Growth in Third Quarter**

**HOUSTON, November 4, 2025** - Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE: FTK), a leader in innovative energy solutions, today announced its financial results for the quarter and nine-months ended September 30, 2025, which reflect continued successful execution of its transformational strategy and robust growth across its two segments.

**Financial Summary** (in thousands, except 'per share' amounts)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **% Change** | **2025** | **2024** | **% Change** |
| Total Revenues | $56031 | $49742 | 13% | $169743 | $136267 | 25% |
| Gross Profit | $17783 | $9119 | 95% | $44639 | $27108 | 65% |
| Net Income | $20355 | $2532 | 704% | $27503 | $6068 | 353% |
| Diluted Income Per Share | $0.53 | $0.08 | 563% | $0.78 | $0.20 | 290% |
| Adjusted EBITDA <sup>(1)</sup> | $11721 | $4840 | 142% | $28953 | $13303 | 118% |

---

**Third Quarter 2025 Highlights:** 

*(all comparisons versus Q3 2024 unless noted)* 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Total revenues increased 13% driven largely by the Data Analytics segment, as the mobile gas conditioning assets acquired in the second quarter of 2025 (the "Acquired Assets") generated $6.1 million of third quarter 2025 revenue.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Data Analytics segment revenues grew to 16% of total revenues, up from 5% in third quarter 2024, helping to deliver total Company gross profit margin of 32%, as compared to 18% in the year-ago quarter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Data Analytics segment gross profit margin totaled 71% during the third quarter of 2025 as compared to 44% during the year-ago quarter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net income totaled $20.4 million, or $0.53 per diluted share, compared to $2.5 million, or $0.08 per diluted share, in the year-ago quarter. Third quarter 2025 net income included a $12.6 million tax benefit, as further discussed below.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted EBITDA<sup>(1)</sup> increased by 142% to $11.7 million, compared to $4.8 million in the year-ago quarter, representing the twelfth consecutive quarter of growth.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• On October 29, 2025, Flotek announced that the XSPCT<sup>TM</sup> analyzer was the first optical spectrometer to comply with GPA 2172 (O&G Custody Transfer Standard)

**2025 Guidance Update:** Based on strong year-to-date operational performance and the outlook for the fourth quarter, the Company is increasing its 2025 guidance ranges as follows ($MMs):

---

| | | |
|:---|:---|:---|
| | **Previous Guidance** | **Revised Guidance** |
| Total Revenues | $200-$220 | $220-$225 |
| Adjusted EBITDA <sup>(2)</sup> | $34-$39 | $35-$40 |

---

![blueflotekfooter2.jpg](blueflotekfooter2.jpg)

------

![blueflotekheader.jpg](blueflotekheader.jpg)

**Management Commentary**

Chief Executive Officer Dr. Ryan Ezell commented, "Flotek delivered an outstanding third quarter, highlighted by reporting total Company gross profit margin of 32%. Throughout the quarter, we continued successfully executing our corporate strategy to transform Flotek into a data-driven technology enterprise. Our Data Analytics segment delivered quarterly revenue comparable to the full year 2024, reflecting accelerated adoption of our advanced analytics solutions supporting the industrial pivot within the energy infrastructure sector. Our Chemistry Technologies segment continued to expand market share, driven by strong demand for our innovative chemical solutions that enhance reservoir performance. Through the first three quarters of 2025, Chemistry segment revenues were 17% higher year-over-year. Our third quarter results underscore the strength in each of our segments and demonstrate our disciplined execution and steadfast commitment to creating value for our customers and shareholders even in challenging market conditions."

**Segment Revenue Summary** (in thousands)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **% Change** | **2025** | **2024** | **% Change** |
| **Chemistry Technologies:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;External Revenues | $20221 | $14097 | 43% | $64773 | $42143 | 54% |
| &nbsp;&nbsp;&nbsp;&nbsp;Related Party Revenues | 26956 | 32977 | (18)% | 87562 | 87732 | —% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $47177 | $47074 | —% | $152335 | $129875 | 17% |
| **Data Analytics:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Product Revenues | $1694 | $1681 | 1% | $5176 | $3920 | 32% |
| &nbsp;&nbsp;&nbsp;&nbsp;Service Revenues <sup>(3)</sup> | 7160 | 987 | 625% | 12232 | 2472 | 395% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $8854 | $2668 | 232% | $17408 | $6392 | 172% |

---

**Revenues:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Chemistry Technologies**: The segment grew external revenue 43% as compared to the year-ago quarter. This growth reflects Flotek's ability to continue to capture market share despite a 25% year-over-year decline in North American frac fleets<sup>(4)</sup>, indicating strong demand for our specialized chemistry solutions. However, related party chemistry purchases were impacted negatively by reduced fleet count utilization.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Data Analytics**: The segment achieved a 232% revenue increase as compared to the year-ago quarter, with service revenues growing more than 625% to $7.2 million, underscoring the growing market demand for Flotek's data-driven solutions that enhance operational efficiency for clients. Third quarter 2025 service revenues include approximately $6.1 million related to the Acquired Assets.

**Gross Profit:** The Company generated gross profit of $17.8 million during the third quarter of 2025 compared to $9.1 million during the third quarter of 2024. The 95% increase in third quarter 2025 gross profit was driven by a 232% increase in high-margin Data Analytics revenue. Additionally, the reduction in related party chemistry sales, as compared to the year-ago quarter, resulted in a 28% increase in revenues attributable to the minimum chemistry purchase requirement contained in the Company's long-term supply agreement with ProFrac. Gross profit as a percentage of revenue totaled 32% in the third quarter of 2025 as compared to 18% in the year-ago period.

![blueflotekfooter2.jpg](blueflotekfooter2.jpg)

------

![blueflotekheader.jpg](blueflotekheader.jpg)

**Selling, General and Administrative ("SG&A") Expense:** SG&A expense totaled $7.4 million for the third quarter of 2025, or 13% as a percentage of revenues, compared to $5.7 million during the third quarter of 2024, or 11% as a percentage of revenues. The increase in SG&A expenses during the third quarter of 2025 was primarily the result of higher professional fees and personnel costs including non-cash stock compensation costs.

**Net Income:** In the third quarter of 2025, Flotek reported net income of $20.4 million, or $0.53 per diluted share, as compared to $2.5 million, or $0.08 per diluted share, in the year-ago quarter. Net income during the third quarter of 2025 included a $12.6 million tax benefit related to previously reserved deferred tax assets. While the current quarter impact of the partial release of the valuation allowance is non-cash, it is a positive indication of the Company's outlook for generating future income from which it could utilize its deferred tax assets.

**Adjusted EBITDA**<sup>(1)</sup> **(Non-GAAP):** Adjusted EBITDA<sup>(1)</sup> was $11.7 million in the third quarter of 2025 as compared to $4.8 million in the third quarter of 2024. This marks the 12th consecutive quarter of Adjusted EBITDA<sup>(1)</sup> improvement.

**PWRtek**<sup>TM</sup> **Update:** During the third quarter of 2025, revenues attributable to the Acquired Assets totaled $6.1 million with gross profit as a percentage of revenue totaling approximately 89%. As of September 30, 2025, all the Acquired Assets were in service and the Company expects fourth quarter and full year 2025 PWRtek revenues to total approximately $6.8 million and $16.1 million, respectively. Acquisition expenses related to the asset acquisition during the third quarter and nine-month periods of 2025 totaled $0.2 million and $4.4 million, respectively.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Represents a non-GAAP measure, see the "Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings" table in this release for more information about this measure, including reconciliations to the most comparable GAAP measures.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)A non-GAAP financial measure. See the "Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings" table in this release for more information about this measure. We are unable to reconcile this forward-looking non-GAAP financial measure to the most directly comparable GAAP financial measure without unreasonable efforts, as we are unable to predict with a reasonable degree of certainty the impact of certain items that would be expected to impact the GAAP financial measure, including, among other items, certain stock-based compensation costs, interest costs related to fluctuations in borrowings outstanding under the Company's asset based loan and the impact of the revaluation of certain liabilities, which is based upon our future stock price. These items do not impact the non-GAAP financial measure.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)Service revenues during the three- and nine-month 2025 periods include $6.1 million and $9.3 million respectively, related to PWRtek rental revenues.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)Comparison according to *Primary Vision* Active U.S. Fracturing Operation Fleet Counts on 9/26/2025 of 179 compared to 9/28/2024 of 238.

**Conference Call Details**

The Company plans to host its earnings conference call on Wednesday, November 5, 2025, at 9:00 a.m. CDT (10:00 a.m. EDT).

Participants may access the call through Flotek's website at https://ir.flotekind.com under the "News & Events" section, by telephone toll free at 1-800-836-8184 (international toll: 1-646-357-8785), or by using the following link to access the audience view of the webcast at https://app.webinar.net/NLao0z9kmlg approximately five minutes prior to the start of the call. Following the conclusion of the conference call, a recording of the call will be available on the Company's website.

**About Flotek Industries, Inc.**

Flotek Industries, Inc. is a leading chemistry and data technology company focused on servicing the Energy industry. The Company's technologies leverage near real-time data to deliver innovative solutions to maximize customer returns. Flotek has an intellectual property

![blueflotekfooter2.jpg](blueflotekfooter2.jpg)

------

![blueflotekheader.jpg](blueflotekheader.jpg)

portfolio of over 130 patents, over 20 years of field and laboratory data, and a global presence in more than 59 countries.

Flotek has established collaborative partnerships focused on sustainable and optimized chemistry and data solutions, aiming to reduce the environmental impact of energy on land, air, water and people.

Flotek is based in Houston, Texas and its common shares are traded on the New York Stock Exchange under the ticker symbol "FTK." For additional information, please visit www.flotekind.com.

**Forward-Looking Statements**

Certain statements set forth in this press release constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) regarding Flotek Industries, Inc.'s business, financial condition, results of operations and prospects. Words such as will, continue, expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this press release. Although forward-looking statements in this press release reflect the good faith judgment of management, such statements can only be based on facts and factors currently known to management. Consequently, forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Further information about the risks and uncertainties that may impact the Company are set forth in the Company's most recent filing with the Securities and Exchange Commission on Form 10-K (including, without limitation, in the "Risk Factors" section thereof), and in the Company's other SEC filings and publicly available documents. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this press release.

**<u>Investor contact</u>:** 

Mike Critelli

Director of Finance & Investor Relations

E: ir@flotekind.com

![blueflotekfooter2.jpg](blueflotekfooter2.jpg)

------

![blueflotekheader.jpg](blueflotekheader.jpg)

**FLOTEK INDUSTRIES, INC.**

 **UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS**

**(in thousands, except share data)**

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| **ASSETS** | | |
| Current assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $4603 | $4404 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restricted cash | 103 | 102 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net of allowance for credit losses of $716 and $447 at September 30, 2025 and December 31, 2024, respectively | 26767 | 17386 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, related party, net of allowance for credit losses of $0 at each of September 30, 2025 and December 31, 2024, respectively | 44831 | 52370 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories, net | 13232 | 13303 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current assets | 2305 | 2952 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current contract asset | 8179 | 5939 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 100020 | 96456 |
| Long-term contract asset | 56655 | 63105 |
| Property and equipment, net | 20822 | 6178 |
| Right-of-use assets | 3266 | 3326 |
| Deferred tax assets, net | 30351 | 51 |
| Other long-term assets | 1573 | 1680 |
| **TOTAL ASSETS** | $212687 | $170796 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY** |  |  |
| Current liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $35073 | $38073 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | 4925 | 5912 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities, related party | 7248 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | 197 | 48 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest payable, related party | 1008 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current portion of operating lease liabilities | 1216 | 1486 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current portion of finance lease liabilities | 149 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Asset-based loan | 6662 | 4789 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current portion of long-term debt |  | 60 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 56478 | 50368 |
| Deferred revenue, long-term |  | 14 |
| Note payable - related party | 39560 |  |
| Long-term operating lease liabilities | 5887 | 6514 |
| Long-term finance lease liabilities | 264 |  |
| **TOTAL LIABILITIES** | 102189 | 56896 |
| Commitments and contingencies |  |  |
| Stockholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preferred stock, $0.0001 par value, 100,000 shares authorized; no shares issued and outstanding |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock, $0.0001 par value, 240,000,000 shares authorized; 31,102,241 shares issued and 29,989,657 shares outstanding at September 30, 2025; 30,938,073 shares issued and 29,826,508 shares outstanding at December 31, 2024  | 3 | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 433939 | 464620 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive income | 109 | 251 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated deficit | (288805) | (316308) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treasury stock, at cost; 1,112,584 and 1,111,565 shares at September 30, 2025 and December 31, 2024, respectively  | (34748) | (34666) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 110498 | 113900 |
| **TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY** | $212687 | $170796 |

---

![blueflotekfooter2.jpg](blueflotekfooter2.jpg)

------

![blueflotekheader.jpg](blueflotekheader.jpg)

**FLOTEK INDUSTRIES, INC.**

**UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

**(in thousands, except per share data)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| **Revenue:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Revenue from external customers | $22941 | $16565 | $72546 | $47935 |
| &nbsp;&nbsp;&nbsp;&nbsp;Revenue from related party | 33090 | 33177 | 97197 | 88332 |
| **Total revenues** | 56031 | 49742 | 169743 | 136267 |
| **Cost of goods sold** | 38248 | 40623 | 125104 | 109159 |
| **Gross profit** | 17783 | 9119 | 44639 | 27108 |
| **Operating costs and expenses:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Selling, general, and administrative | 7384 | 5714 | 20462 | 18079 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset acquisition expenses | 167 |  | 4362 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 581 | 220 | 1207 | 662 |
| &nbsp;&nbsp;&nbsp;&nbsp;Research and development | 549 | 462 | 1359 | 1349 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of property and equipment |  |  | (7) | (34) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating costs and expenses | 8681 | 6396 | 27383 | 20056 |
| **Income from operations** | 9102 | 2723 | 17256 | 7052 |
| **Other income (expense):** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | (1351) | (256) | (2563) | (842) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income (expense), net | (8) | 102 | 279 | 151 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other expense | (1359) | (154) | (2284) | (691) |
| **Income before income taxes** | 7743 | 2569 | 14972 | 6361 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax benefit (expense) | 12612 | (37) | 12531 | (293) |
| **Net income** | $20355 | $2532 | $27503 | $6068 |
| **Income per common share:** | **Income per common share:** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.57 | $0.09 | $0.83 | $0.21 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $0.53 | $0.08 | $0.78 | $0.20 |
| **Weighted average common shares:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Weighted average common shares used in computing basic income per common share | 35868 | 29613 | 33189 | 29498 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Weighted average common shares used in computing diluted income per common share | 38137 | 30897 | 35420 | 30655 |

---

![blueflotekfooter2.jpg](blueflotekfooter2.jpg)

------

![blueflotekheader.jpg](blueflotekheader.jpg)

**FLOTEK INDUSTRIES, INC.**

**UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(in thousands)**

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** |
| **Cash flows from operating activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income | $27503 | $6068 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in fair value of contingent consideration | (127) | (46) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of contract assets | 4210 | 4341 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 1207 | 662 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of deferred financing costs | 252 | 243 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision for credit losses, net of recoveries | 555 | 121 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision for excess and obsolete inventory | 307 | 626 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of property and equipment | (7) | (34) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-cash lease expense | 840 | 1661 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock compensation expense | 1706 | 915 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax (benefit) expense | (12773) | 233 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in current assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | (9936) | 1346 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, related party | (10013) | (12495) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | 462 | (532) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax receivable | (32) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | 724 | 849 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | (3000) | 5690 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued liabilities | (874) | (1730) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Operating lease liabilities | (1204) | (2002) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | 149 | 9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest payable, related party | 1008 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 957 | 5925 |
| **Cash flows from investing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures | (1697) | (491) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of assets | 7 | 34 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (1690) | (457) |
| **Cash flows from financing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments on long term debt | (60) | (135) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from asset-based loan | 147000 | 122600 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments on asset-based loan | (145127) | (128666) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment of asset-based loan origination costs | (150) | (164) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment of note payable issuance costs | (480) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment of issuance costs of stock warrants | (653) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments to tax authorities for shares withheld from employees | (82) | (30) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of stock under Employee Stock Purchase Plan | 113 | 88 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of stock from stock option exercises | 574 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments for finance leases | (60) | (22) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) financing activities | 1075 | (6329) |
| **Effect of changes in exchange rates on cash and cash equivalents** | (142) | 6 |
| **Net change in cash and cash equivalents and restricted cash** | 200 | (855) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents at the beginning of period | 4404 | 5851 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restricted cash at the beginning of period | 102 | 102 |
| **Cash and cash equivalents and restricted cash at beginning of period** | 4506 | 5953 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents at end of period | 4603 | 4997 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restricted cash at the end of period | 103 | 101 |
| **Cash and cash equivalents and restricted cash at end of period** | $4706 | $5098 |

---

![blueflotekfooter2.jpg](blueflotekfooter2.jpg)

------

![blueflotekheader.jpg](blueflotekheader.jpg)

**FLOTEK INDUSTRIES, INC.**

**UNAUDITED RECONCILIATION OF NON-GAAP ITEMS AND NON-CASH ITEMS IMPACTING EARNINGS**

**(in thousands)**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Twelve Months Ended<br>December 31,** |
| | **2025** | **2024** | **2025** | **2024** | **2024** |
| **Net income** | $20355 | $2532 | $27503 | $6068 | $10498 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 1351 | 256 | 2563 | 842 | 1095 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax (benefit) expense | (12612) | 37 | (12531) | 293 | 649 |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 581 | 220 | 1207 | 662 | 891 |
| **EBITDA (Non-GAAP)** <sup>(1)</sup> | $9675 | $3045 | $18742 | $7865 | $13133 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock compensation expense | 569 | 272 | 1706 | 915 | 1366 |
| &nbsp;&nbsp;&nbsp;&nbsp;Severance and retirement | 16 |  | 67 | 32 | 39 |
| &nbsp;&nbsp;&nbsp;&nbsp;Contingent liability revaluation |  | (19) | (127) | (46) | 71 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on disposal of asset |  |  | (7) | (34) | (124) |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of contract asset <sup>(2)</sup> | 1294 | 1592 | 4210 | 4341 | 5612 |
| &nbsp;&nbsp;&nbsp;&nbsp;Non-Recurring professional fees <sup>(3)</sup> | 167 | (50) | 4362 | 230 | 230 |
| **Adjusted EBITDA (Non-GAAP)** <sup>(1)</sup> | $11721 | $4840 | $28953 | $13303 | $20327 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Management believes that EBITDA and Adjusted EBITDA for the three and nine months ended September 30, 2025 and 2024, and for the twelve months ended December 31, 2024 are useful to investors to assess and understand operating performance, especially when comparing those results with previous and subsequent periods. Management views the adjustments made to net income for certain non-cash or non-recurring items noted above to be outside of the Company's normal operating results. Management analyzes operating results without the impact of the above items as an indicator of performance, to identify underlying trends in the business and cash flow from continuing operations, and to establish financial, compensation and operational objectives. In addition, the Company believes that Adjusted EBITDA provides investors, creditors and analysts with a clearer view of the Company's leverage profile and debt service capacity, enhancing comparability and augmenting the ability of investors, creditors and analysts to make investment decisions based upon liquidity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)The Company's contract assets arose from fixed, non-refundable consideration in the form of convertible notes issued by the Company to ProFrac in connection with the entry into the ProFrac Agreement and are amortized as a reduction of revenue over the contract term. While the GAAP presentation reduces revenue, these amounts economically represent the cost of acquiring the ProFrac Agreement, similar to commissions, marketing spend or other customer acquisition expenses. Accordingly, the Company's management treats the amortization of contract assets similar to a non-cash expense added-back to arrive at Adjusted EBITDA to more accurately reflect the recurring cash impact of the transaction and to maintain comparability with the treatment of other amortization costs and comparability of the Company's results with competitors that may not report amortization of contract assets. The Company believes that it is important for investors to understand that under GAAP, the amortization of contract assets is not an expense and instead reduces revenue.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)Includes $0.2 million and $4.4 million of expenses related to Asset Acquisition for the three and nine months ended September 30, 2025, respectively.

![blueflotekfooter2.jpg](blueflotekfooter2.jpg)

## Exhibit 99.2

![](flotek3q2025earningspres001.jpg)

Third Quarter 2025 Earnings Presentation November 4, 2025

------

![](flotek3q2025earningspres002.jpg)

Forward-Looking Statements Certain statements set forth in this presentation constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) regarding Flotek Industries, Inc.'s business, financial condition, results of operations and prospects. Words such as will, continue, expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this presentation. Although forward-looking statements in this presentation reflect the good faith judgment of management, such statements can only be based on facts and factors currently known to management. Consequently, forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements. Further information about the risks and uncertainties that may impact the Company are set forth in the Company's most recent filing with the Securities and Exchange Commission on Form 10-K and Form 10-Q (including, without limitation, in the "Risk Factors" section thereof), and in the Company's other SEC filings and publicly available documents. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this presentation. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this presentation. This presentation includes certain non-GAAP measures. Please refer to the reconciliations provided in the earnings press release and the appendix in this presentation for the most comparable GAAP measure. // 2

------

![](flotek3q2025earningspres003.jpg)

// 3 12 Consecutive Quarters of Improved Adj. EBITDA\* Growing High-Margin Data Analytics Backlog Long-term Contracts Insulate Market Risk Outstanding HS&E Record Flotek Industries CHEMISTRY AS THE COMMON VALUE CREATION PLATFORM Proven Top-tier Leadership Team \* Adjusted EBITDA is a non-GAAP measure. See the Appendix in this presentation for a reconciliation to the most comparable GAAP measure Pioneering Data & Chemistry Technology

------

![](flotek3q2025earningspres004.jpg)

CONVERGENCE OF INNOVATIVE DATA AND CHEMISTRY SOLUTIONS Execution of a Data Driven Industrial Pivot // 4 92% 8% 2024 75% 25% 2025\* 40% 50% 10% Convergence Future \* Year to Date September 30, 2025 \*\* January 1, 2026 through April 2031; assumes rental revenue in the 6th year is consistent to the fixed rates of year 5 (year 6 subject to prevailing market rates) \*\*\* Estimated based upon data provided by Enverus, Spears OMR, IEA, Technvio, and DEP • Expanded Upstream service revenue expected to drive Data Analytics gross profit contribution – Power Services' & Digital Valuation building on $148MM\*\* in high-margin backlog through 2031 – Automated completion, production, & water chemistry treatment via real-time monitoring • Total Addressable Market (+$15B\*\*\*) is expected to provide significant growth opportunities Segment Gross Profit Contribution

------

![](flotek3q2025earningspres005.jpg)

// 5 Strategy Drives Shareholder Value -$10 -$8 -$6 -$4 -$2 $0 $2 $4 $6 $8 $10 $12 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 1Q25 2Q25 3Q25 Ad j. EB IT DA \* ($M M 's) \* Adjusted EBITDA is a non-GAAP measure. See the Appendix in this presentation for a reconciliation to the most comparable GAAP measure \* \* Stock price growth reflects 2yr FTK closing price from October 30, 2023 vs. October 30, 2025 10yr PF Supply Contract Executive Leadership Change Established PWRtek LLC 337% Stock Price Growth \*\* Chemistry & Data Innovation Creates Shareholder Value Measure-More Strategy Data Analytics Enters Upstream Market $11.7 Custody Transfer GPA 2172

------

![](flotek3q2025earningspres006.jpg)

13% 87% 3Q24 Gross Profit Data Analytics Chemistry Technologies Continued Quarter Over Quarter Growth // 6 Sustainable chemistry solutions to maximize customer's value chain while minimizing their environmental impact Transforming business through real-time data, monitoring and process control across the energy value chain utilizing proprietary technologies Chemistry Technologies Data Analytics 232% GROWTH IN HIGH MARGIN DATA ANALYTICS REVENUES FLOTEK INDUSTRIES PROFILE: Founded: 1985 Employees: 162 Headquarters: Houston Patents: >130 35% 65% 3Q25 Gross Profit $9.1MM $17.8MM

------

![](flotek3q2025earningspres007.jpg)

• Significantly increased revenue, gross profit, net income and adjusted EBTIDA\* vs year-ago quarter • 232% increase in Data Analytics (DA) revenue compared to 3Q24; 3Q25 DA revenue equaled full year 2024 • Increased 2025 Revenue and Adj. Ebitda\* guidance ranges • Realized $12.6 MM tax benefit in 3Q25 related to the Company's valuation allowance on deferred tax assets • On 10/29/25 announced XSPCT is first optical device to meet GPA 2172 (Custody Transfer Standard) Flotek 3Q25 Highlights // 7 7TH CONSECUTIVE QUARTER OF GROWTH IN GROSS PROFIT AND ADJ. EBITDA\* \* Adjusted EBITDA is a non-GAAP measure. See the Appendix in this presentation for a reconciliation to the most comparable GAAP measure In $MM 3Q25 3Q24 % Change Revenue $56.0 $49.7 13% Gross Profit $17.8 $9.1 95% Gross Margin % 32% 18% 78% Net Income $20.4 $2.5 704% Adj. EBITDA\* $11.7 $4.8 142% Diluted EPS $0.53 $0.08 563%

------

![](flotek3q2025earningspres008.jpg)

Financial Momentum Driven By Strong Growth // 8 Quarterly Adjusted EBITDA\* Growth \* Adjusted EBITDA is a non-GAAP measure. See the Appendix in this presentation for a reconciliation to the most comparable GAAP measure \*\* A non-GAAP financial measure. See the "Unaudited Reconciliation of Non-GAAP Items and Non-Cash Items Impacting Earnings" tables in the appendix for more information about this measure. We are unable to reconcile this forward-looking non-GAAP financial measure to the most directly comparable GAAP financial measure without unreasonable efforts, as we are unable to predict with a reasonable degree of certainty the impact of certain items that would be expected to impact the GAAP financial measure, including, among other items, certain stock-based compensation costs, interest costs related to fluctuations in borrowings outstanding under the Company's asset based loan and the impact of the revaluation of certain liabilities, which is based upon our future stock price. These items do not impact the non-GAAP financial measure. $(5.1) $11.7 -$6.0 -$4.0 -$2.0 $0.0 $2.0 $4.0 $6.0 $8.0 $10.0 $12.0 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 1Q25 2Q25 3Q25 Ad j. EB IT DA \* ($M M 's) 12 CONSECUTIVE QUARTERS OF PROFITABILITY IMPROVEMENT FY 2025 GUIDANCE Metric Guidance Range Mid-Point vs. 2024 Total Revenue: $220MM - $225MM +19% Adj. EBITDA\*\*: $35MM - $40MM +85% • Increased guidance ranges (vs 1Q25 initial estimates) on total revenue and Adj. EBITDA\*\* by 6% and 3%, respectively • $37.5 million Adj. EBITDA\*\* (Mid-Point) would represent the highest in more than decade

------

![](flotek3q2025earningspres009.jpg)

Data Analytics: "Measure More Strategy" Upstream • Power Services: facilitates natural gas utilization in powering turbines and dual-fuel engines • Digital Valuation: delivers real-time product values for faster & more accurate Custody Transfer reporting • Flare Monitoring: assisting in the compliance of EPA regulations and enhanced flare efficiency control • Chemical Treatment: Autonomous & Continuous completion chemistry monitoring & treatment Midstream • Gas/Oil processing plant control and optimization • TransMix Pipeline batch detection to optimize pipeline transfer processes • Vapor Pressure Monitoring controls to achieve product specifications • Chemical Treatment: Autonomous & Continuous production/water chemistry monitoring & treatment Downstream • Process Controls: to optimize distillation tower efficiency • Chemical Quality Measurements in pipelines and terminals • Carbon Capture measurement for carbon credits and reporting UTILIZING TECHNOLOGIES FOR EXPANSION INTO NEW MARKETS // 9 Growth Emerging Markets 2026

------

![](flotek3q2025earningspres010.jpg)

THE CONVERGENCE OF CHEMISTRY AND DATA SOLUTIONS IN UPSTREAM COMPLETION CHEMISTRY // 10 Innovation & Strategy Drive Market Expansion DIGITAL VALUATION MOBILE POWER GENERATION FLARE MONITORING GRID & DATA CENTER POWER GENERATION U P S T R E A M Water Treatment

------

![](flotek3q2025earningspres011.jpg)

SERVICE REVENUE\* GREW 625% SINCE Q3 2024 Data Analytics High Margin Revenue Growth • 3Q25 DA revenues equaled full year 2024 DA revenues • Data Analytics segment revenues grew to 16% of total revenue, up from 5% in 3Q24 • 2026 revenues attributable to PWRtekTM expected to exceed $27mm Asset Acquisition // 11 $1.7 $0.9 $1.6 $1.8 $1.7 $1.0 $1.6 $1.0 $4.1 $7.2 44% 39% 38% 63% 71% 0% 10% 20% 30% 40% 50% 60% 70% 80% $- $1.0 $2.0 $3.0 $4.0 $5.0 $6.0 $7.0 $8.0 3Q24 4Q24 1Q25 2Q25 3Q25 Product Revenue Service Revenue Gross Profit % \*Service revenues include rental related revenues

------

![](flotek3q2025earningspres012.jpg)

Data Analytics: Power Services // 12 PATENTED TECHNOLOGY ENABLES SCALABLE, LOW COST, GRID-FREE ENERGY, & ENGINE PROTECTION City Gas CNG Field Gas Waste/Biogas Measure Control Distribute Reciprocating Engine Gas Turbine Engine Control Module BTU CH4 Number HHV LHV Wobbe Index H2S and CO2 Volume Density ESD Protection Liquids Separation Blending Scrubbing Durability Efficiency Smaller Footprint Emissions Pressure Temperature Plug N Play Redundancy Optimize Volume Diesel (Blending Substitute) Alternative Fuel Source Incumbent Fuel Source

------

![](flotek3q2025earningspres013.jpg)

Data Analytics: Digital Valuation // 13 Achieving GPA 2172 Standard: • The XSPCTTM is the first optical spectrometer to comply with GPA 2172 • Five XSPCT TM units, in an Eagleford test, exceeded 95% pass rates for methane, ethane, propane, and higher hydrocarbons Customer Update: • Currently targeting expansion to over 200 potential XSPCT TM installations across multiple customers • On target to have a total of 25-35 units placed into service by year-end XSPCTTM CONTINUES TO EXPAND DATA ANALYTICS DAAS REVENUE XSPCT Analyzer Installed on customer location in the DJ Basin

------

![](flotek3q2025earningspres014.jpg)

Data Analytics: XSPCT GPA 2172 // 14 FIRST OPTICAL SPECTROMETER TO MEET GPA 2172 CUSTODY TRANSFER STANDARD What Does This Mean? 1. XSPCT can operate at the same precision levels expected from online GC (autosampler) 2. XSPCT units meet ATSM standards for Digital Valuation of Hydrocarbons (Custody Transfer) 3. Reduced barrier for Customer Adoption

------

![](flotek3q2025earningspres015.jpg)

Data Analytics: VeraCal Flare Solution // 15 LEADING FLARE OOOOb/c MEASUREMENT SOLUTION Pictured above: The proprietary VeraCal mobile flaring cart on location EPA Approval on Flaring Measurement Application • VeraCal was the first EPA approved alt. measurement solution • EPA proposed amendments in December 2024 delayed market demand Our Flare Measurement System is Differentiated • Rugged, simple installation on Combustor, Flare, VRU or ECD • Continuous and autonomous monitoring • No consumable calibration gas Customer Emission Savings via EPA Subpart-W • 4-6% additional savings in emission penalties • Gain 3-4% in production before Super Emitter Status

------

![](flotek3q2025earningspres016.jpg)

// 16 • Prescriptive Chemistry Management (PCM)TM – Proprietary energy chemistry solutions – Experienced chemistry energy team – Customized solutions to each well's geology • AI Driven Analytics from >20,000 wells • Real-Time Field Data to Enhance Performance • Field Correlated Diagnostics • +130 Patents DELIVERING TOP TIER WELL PERFORMANCE IN INDUSTRY Chemistry Technologies: Competitive Advantage

------

![](flotek3q2025earningspres017.jpg)

Chemistry Growth in a Contracting Market // 17 • 54% growth in 9MTD25 external chemistry vs. 9MTD24 • 21% increase in total chemistry revenue\*\* (9MTD25 vs 9MTD24) despite a (24%) drop in avg. fleet count • Fleet counts on Sep. 30th, 2024: 238 vs. Sep. 30th, 2025: 179 FLOTEK GAINS MARKET SHARE IN A CONTRACTING MARKET \*Related Party Chemistry Technology revenues exclude the order shortfall payment "OSP" \*\*Chemistry Technology Revenue excludes Related Party order shortfall payment "OSP" \*\*\*Fleet Count numbers pulled from Primary Vision 50%50% 9MTD25 Chemistry Revenue\*\* External Related Party\* $106 $128 248 188 160 170 180 190 200 210 220 230 240 250 260 $70 $80 $90 $100 $110 $120 $130 9MTD24 9MTD25 Av g. F ra c f le et C ou nt \* \*\* Re ve nu e ($ M M) Total Chemistry Revenue\*\* Chemistry Revenue\*\* Avg. Frac Fleet Count

------

![](flotek3q2025earningspres018.jpg)

THE CONVERGENCE OF DATA AND CHEMISTRY SOLUTIONS COMPLETION CHEMISTRY FRAC POWER GENERATION TRANSMIX MONITORING TREATMENT/STABILIZATION FLARE MONITORING DATA CENTER POWER GRID POWER TERMINAL & STORAGE MONITORING LNG TERMINALING AND EXPORTATION WATER TREATMENT ACID TREATMENT CEMENTING ADDITIVES // 18 Innovation & Strategy Drive Market Expansion \* Estimated based upon data provided by Enverus, Spears OMR, IEA, Technvio, and DEP ADDRESSABLE MARKET GROWTH 2021: $2.6B 2025: ~$15B+ \*

------

![](flotek3q2025earningspres019.jpg)

$- $2.00 $4.00 $6.00 $8.00 $10.00 $12.00 $14.00 $16.00 $18.00 $20.00 // 19 Flotek Industries 3Q25 Summary CHEMISTRY AS THE COMMON VALUE CREATION PLATFORM FTK 337%\* • Stock Chart tracks 2yr FTK closing price from October 30, 2023 through October 30, 2025 \* \* Adjusted EBITDA is a non-GAAP measure. See the Appendix in this presentation for a reconciliation to the most comparable GAAP measure  Data Analytics: Achieved 232% revenue growth and 430% gross profit expansion vs 3Q24  Digital Valuation: 25+ installations expected to be active by YE  Power Services: Delivered ~90% gross margin  External Chemistry Technologies: Grew revenue by 43% vs 3Q24 despite a challenging oilfield market  Sustained Profitability: Reported 12th consecutive quarter of improved Adjusted EBITDA\*\*  Safety Leadership: Maintained a proven safety culture with an exemplary track record

------

![](flotek3q2025earningspres020.jpg)

// 20 Permian Basin BBQ Cookoff November 11-12th 2025 Scharbauer Sports Complex Midland, TX INVEST Houston 2nd Edition November 20th 2025 JW Marriott Houston, TX DEP NY Executive Series December 3, 2025 Nasdaq New York City, NY 14th Annual ROTH Deer Valley Event December 10-13th 2025 Park City, UT Northland Growth Conference December 16th 2025 Virtual Investor Contact: Mike Critelli Director of Finance & Investor Relations ir@flotekind.com Upcoming 2025 Events JOIN US

------

![](flotek3q2025earningspres021.jpg)

Appendix

------

![](flotek3q2025earningspres022.jpg)

Data Analytics: Recurring Revenue Backlog // 22 • 2026 revenue backlog expected to exceed 2024 total segment revenues by 221% • Power Services' lease agreement generates $148MM\*\* in high-margin backlog through 2031 • Digital Valuation services launched first revenue- generating Data-as-a-Service installations in 2Q25, boosting future growth opportunity POWER SERVICES SIGNIFICANTLY IMPROVES ANNUAL REVENUE BACKLOG $28.6 $28.6 $28.2 $28.2 $27.4 $- $5 $10 $15 $20 $25 $30 $35 2026 2027 2028 2029 2030 Co nt ra ct ed R ec ur rin g Re ve nu e ($ M M 's) Data Analytics Recurring Contracted Backlog\* \*Includes PWRtek Lease Agreement and annual contractual services \*\*January 1, 2026 through April 2031; assumes rental revenue in the 6th year is consistent to the fixed rates of year 5 (year 6 subject to prevailing market rates)

------

![](flotek3q2025earningspres023.jpg)

Data Analytics: XSPCT GPA 2172 // 23 FIRST OPTICAL SPECTROMETER TO MEET GPA 2172 CUSTODY TRANSFER STANDARD GPA 2172 (API 14.5) is the O&G industry standard for calculating gross heating value (GHV), relative density, and compressibility factor from compositional analysis GPA 2172-19 (API 14.5): • Defines how to calculate GHV and related properties from measured composition • Used directly in custody transfer billing • Recognizes that sample analysis may come from GPA 2261 GC or other technically acceptable methods, including optical spectroscopy that meet reproducibility requirements GPA 2261-20 (Gas Chromatography Analysis): • Sets criteria for reproducibility and performance acceptance between labs/instruments • FTK NIR methods (per GPA 2119 / ASTM D6122) are benchmarked against these limits GPA 2119-24 (Optical Spectroscopy Analysis): • Defines how optical spectroscopy can be used to determine hydrocarbon composition • This is the direct validation pathway for FTK analyzers ASTM D6122: • Provides validation procedures for multivariate NIR/IR analyzers • Ensures models meet performance standards before being accepted for use

------

![](flotek3q2025earningspres024.jpg)

Maximizing Customer Return on Investment Data Analytics/Physics Based Modeling on >20k Wells • +10 years Field Completion Data • Reservoir Similarities and Physicochemical Properties • Production Uplift Curve Analysis • Basin Water and Frac Water Properties A Decade of Data with Predictive Models • Polymer Viscosity & Friction Reduction Predictions • Clay Stabilization Analytics • Scale Inhibitor Database • Formation Damage Mechanism Identification Aligning Support with Vendors and Customers • Leverage vendor data where applicable • Utilize databases to streamline analytical procedures DATA-DRIVEN GEOCENTRIC MODELING DELIVERS PRECISION CHEMISTRY SOLUTIONS // 24

------

![](flotek3q2025earningspres025.jpg)

// 25 Recent Financials Unaudited Condensed Consolidated Balance Sheets (in thousands, except share data)

------

![](flotek3q2025earningspres026.jpg)

Recent Financials Unaudited Condensed Consolidated Statement of Operations (in thousands) // 26

------

![](flotek3q2025earningspres027.jpg)

// 27 Recent Financials Unaudited Condensed Consolidated Statements of Cash Flows (in thousands)

------

![](flotek3q2025earningspres028.jpg)

// 28 1) Management believes that EBITDA and Adjusted EBITDA for the three and nine months ended September 30, 2025 and 2024, and for the twelve months ended December 31, 2024 are useful to investors to assess and understand operating performance, especially when comparing those results with previous and subsequent periods. Management views the adjustments made to net income for certain non-cash or non-recurring items noted above to be outside of the Company's normal operating results. Management analyzes operating results without the impact of the above items as an indicator of performance, to identify underlying trends in the business and cash flow from continuing operations, and to establish financial, compensation and operational objectives. In addition, the Company believes that Adjusted EBITDA provides investors, creditors and analysts with a clearer view of the Company's leverage profile and debt service capacity, enhancing comparability and augmenting the ability of investors, creditors and analysts to make investment decisions based upon liquidity. 2) The Company's contract assets arose from fixed, non-refundable consideration in the form of convertible notes issued by the Company to ProFrac in connection with the entry into the ProFrac Agreement and are amortized as a reduction of revenue over the contract term. While the GAAP presentation reduces revenue, these amounts economically represent the cost of acquiring the ProFrac Agreement, similar to commissions, marketing spend or other customer acquisition expenses. Accordingly, the Company's management treats the amortization of contract assets similar to a non-cash expense added-back to arrive at Adjusted EBITDA to more accurately reflect the recurring cash impact of the transaction and to maintain comparability with the treatment of other amortization costs and comparability of the Company's results with competitors that may not report amortization of contract assets. The Company believes that it is important for investors to understand that under GAAP, the amortization of contract assets is not an expense and instead reduces revenue. 3) Includes $0.2 million and $4.4 million of expenses related to the Asset Acquisition for the three and nine months ended September 30, 2025, respectively. Recent Financials Unaudited Reconciliation of Non-GAAP Items & Non-Cash Items Impacting Earnings (in thousands)(1)

------

![](flotek3q2025earningspres029.jpg)

// 29 1) Management believes that EBITDA and Adjusted EBITDA for all periods above are useful to investors to assess and understand operating performance, especially when comparing those results with previous and subsequent periods. Management views the adjustments made to net income for certain non-cash or non-recurring items noted above to be outside of the Company's normal operating results. Management analyzes operating results without the impact of the above items as an indicator of performance, to identify underlying trends in the business and cash flow from continuing operations, and to establish financial, compensation and operational objectives. In addition, the Company believes that Adjusted EBITDA provides investors, creditors and analysts with a clearer view of the Company's leverage profile and debt service capacity, enhancing comparability and augmenting the ability of investors, creditors and analysts to make investment decisions based upon liquidity. 2) The Company's contract assets arose from fixed, non-refundable consideration in the form of convertible notes issued by the Company to ProFrac in connection with the entry into the ProFrac Agreement and are amortized as a reduction of revenue over the contract term. While the GAAP presentation reduces revenue, these amounts economically represent the cost of acquiring the ProFrac Agreement, similar to commissions, marketing spend or other customer acquisition expenses. Accordingly, the Company's management treats the amortization of contract assets similar to a non-cash expense added-back to arrive at Adjusted EBITDA to more accurately reflect the recurring cash impact of the transaction and to maintain comparability with the treatment of other amortization costs and comparability of the Company's results with competitors that may not report amortization of contract assets. The Company believes that it is important for investors to understand that under GAAP, the amortization of contract assets is not an expense and instead reduces revenue. Past Financials Unaudited Reconciliation of Non-GAAP Items & Non-Cash Items Impacting Earnings (in thousands)(1)

------

![](flotek3q2025earningspres030.jpg)

// 30 1) Management believes that EBITDA and Adjusted EBITDA for all periods above are useful to investors to assess and understand operating performance, especially when comparing those results with previous and subsequent periods. Management views the adjustments made to net income for certain non-cash or non-recurring items noted above to be outside of the Company's normal operating results. Management analyzes operating results without the impact of the above items as an indicator of performance, to identify underlying trends in the business and cash flow from continuing operations, and to establish financial, compensation and operational objectives. In addition, the Company believes that Adjusted EBITDA provides investors, creditors and analysts with a clearer view of the Company's leverage profile and debt service capacity, enhancing comparability and augmenting the ability of investors, creditors and analysts to make investment decisions based upon liquidity. 2) The Company's contract assets arose from fixed, non-refundable consideration in the form of convertible notes issued by the Company to ProFrac in connection with the entry into the ProFrac Agreement and are amortized as a reduction of revenue over the contract term. While the GAAP presentation reduces revenue, these amounts economically represent the cost of acquiring the ProFrac Agreement, similar to commissions, marketing spend or other customer acquisition expenses. Accordingly, the Company's management treats the amortization of contract assets similar to a non-cash expense added-back to arrive at Adjusted EBITDA to more accurately reflect the recurring cash impact of the transaction and to maintain comparability with the treatment of other amortization costs and comparability of the Company's results with competitors that may not report amortization of contract assets. The Company believes that it is important for investors to understand that under GAAP, the amortization of contract assets is not an expense and instead reduces revenue. 3) Includes $4.2 million of expenses related to the Asset Acquisition for the three months ended June 30, 2025. Past Financials Unaudited Reconciliation of Non-GAAP Items & Non-Cash Items Impacting Earnings (in thousands)(1)

------